WASHINGTON, and IRVINE, Calif., April 16, 2018 /PRNewswire/ — Ivantis Inc., developer of the novel Hydrus® Microstent, a device designed to lower eye pressure for open-angle glaucoma patients, announced today the 12-month results of the COMPARE study for minimally invasive glaucoma…



Source link